Long COVID: with one in three patients back in hospital after three months, where are the treatments?

By Mark Toshner, Lecturer in Translational Respiratory Medicine, University of Cambridge

The pace of acute therapy and vaccine development for COVID have been dizzying. But even as we hope a route to bringing the pandemic under control is within sight, we’re now facing the possibility of another urgent public health emergency thanks to what’s known as long COVID, a group of symptoms that last long after the initial infection. With such a potential crisis looming, it is reasonable to ask what we are doing about it, and why treatments don’t appear to be forthcoming.

There are a few reasons why the long COVID story may pan out differently. Let’s take the first problem: long…

Read complete article

~	A Hong Kong Facebook group on shop closure strives to survive allegations of inciting discontent

~	Vaping now more common than smoking among young people – and the risks go beyond lung and brain damage

~	Burkina Faso: Army Massacres 223 Villagers

~	Lebanon: Stepped-Up Repression of Syrians

~	Africa’s High Teenage Pregnancy Rate Demands Strong Response

~	Inflation is slowly falling while student debt is climbing: 6 graphs that explain the CPI

~	‘It bucked our lads up wonderfully’: the lightning-quick battle that marked the birth of the US-Australia military alliance

~	If plastic manufacturing goes up 10%, plastic pollution goes up 10% – and we’re set for a huge surge in production

~	Ancient nomads you’ve probably never heard of disappeared from Europe 1,000 years ago. Now, DNA analysis reveals how they lived

~	Iran: Popular Rapper Sentenced to Death for Dissent